Navigation Links
Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
Date:4/7/2008

Although Some Emerging Therapies Hold Promise, Enbrel Will Remain the

Clinical Gold Standard Through 2016, According to a New Report from

Decision Resources

WALTHAM, Mass., April 7, 2008 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's effect on inhibiting/slowing the progression of structural damage and reducing the signs and symptoms of rheumatoid arthritis during the first year of treatment are the attributes that most influence surveyed rheumatologists' prescribing decisions in the treatment of the disease. Clinical data and expert opinion shows that current and emerging therapies have no advantage in these attributes over the market sales leader, Amgen/Wyeth/Takeda's Enbrel.

The new report entitled Rheumatoid Arthritis: Competitive, Crowded Market Sets the Bar High for Novel Agents finds that, through 2016, there are no therapies in development that will displace Enbrel as the clinical gold standard treatment for rheumatoid arthritis. While some therapies in development for the disease hold promise, most have efficacy, safety and tolerability, and/or delivery features that are inferior when compared with Enbrel.

The overall efficacy of emerging therapies such as Centocor/Schering-Plough/Mitsubishi Tanabe/Janssen's golimumab and Biogen Idec/Genentech/Roche's ocrelizumab is comparable to that of Enbrel, while the overall safety and tolerability for emerging therapies that include ocrelizumab and UCB's Cimzia are also comparable to that of Enbrel. However, the currently available clinical data for golimumab, ocrelizumab and Cimzia is not as robust or extensive as those available for Enbrel.

"While emerging therapies such as golimumab and Cimzia offer superior delivery to that of Enbrel due to improved dosing frequencies, these agents' overall efficacy, safety and tolerability, respect
'/>"/>

SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
2. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
3. Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
5. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
6. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
7. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
8. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
9. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
10. First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs
11. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014  Ameritox SM , the ... Deadly Trend: Prescription Drugs to Heroin," a research report ... heroin abuse, and examines deadly trends that have created ... here . The report is ... patients prescribed opioids. It examines five trends that distinguish ...
(Date:9/2/2014)... , September 2, 2014 ... by Transparency Market Research "Latin America Home Healthcare ... Therapeutic Home Healthcare Devices, Mobility Assist Devices and ... Respiratory Therapy, Infusion Therapy and Unskilled Home Healthcare ... and Forecast, 2014 - 2020" the Latin American ...
(Date:9/2/2014)... Sept. 2, 2014   Santa Clara dentist , ... special promotion for Invisalign. Invisalign is an orthodontic system ... It is often the orthodontic treatment of choice for ... aesthetics of it. For a limited time, patients can ... savings from the usual cost. This offer cannot be ...
Breaking Medicine Technology:Ameritox Research Report Reveals Pain Patients' Role in Current Heroin Epidemic 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2
... Oct. 29 , AT A GLANCE , ... PEM significantly improves ability to differentiate between benign ... MRI dramatically increased number of suspicious lesions found. ... women diagnosed with breast cancer found that Positron Emission ...
... Hospira, Inc. (NYSE: HSP ) celebrates the 25th anniversary ... 1984, Hospira,s PCA was the first pump of its kind, ... best when they are in pain, so allow them, within ... PCA technology has improved the safety and quality of care ...
Cached Medicine Technology:High-Resolution Breast PET Improves Breast Cancer Detection 2High-Resolution Breast PET Improves Breast Cancer Detection 3Healthcare Industry Celebrates 25 Years of Advanced Pain Management With PCA Infusion System 2Healthcare Industry Celebrates 25 Years of Advanced Pain Management With PCA Infusion System 3Healthcare Industry Celebrates 25 Years of Advanced Pain Management With PCA Infusion System 4
(Date:9/2/2014)... York (PRWEB) September 02, 2014 - ... defined as a class of diagnostic test that analyzes ... The nucleic acids and proteins that belong to individual ... therapy, health condition, or risk of developing a specific ... better known as (MDx) evaluating the new class of ...
(Date:9/2/2014)... 02, 2014 The new Eco-Pro ... reduce discomfort and fatigue by absorbing stress and impact ... renewable bio-foam core, these anti-fatigue mats are intended for ... to a study by the Texas A&M University, Eco-Pro ... in reducing spinal compression and increase in sit-reach flexibility ...
(Date:9/2/2014)... 2014 A New York City based ... a simple, yet revolutionary, product that will ... reducing health care costs for Americans. , ... that puts control in the user's hands. It's a ... the next date of intake by simply turning a ...
(Date:9/2/2014)... September 02, 2014 Welcome to ... over 4.6 million Canadians living with the disease, The ... of Arthritis” video series featuring well-known Canadians from different ... ,      Lloyd Robertson , veteran news anchor ... medal skier ,      Amy Cotton , ...
(Date:9/2/2014)... Ga. A little white pill may help scientists ... capacity than their peers, even if their lungs are ... sildenafil marketed as Revatio to treat pulmonary hypertension ... a cocktail of over-the-counter antioxidants will help them identify ... exercise difficult for these patients. , "We want ...
Breaking Medicine News(10 mins):Health News:Molecular Diagnostic Market: Global Factors and Perspectives by Transparency Market Research 2Health News:Molecular Diagnostic Market: Global Factors and Perspectives by Transparency Market Research 3Health News:Molecular Diagnostic Market: Global Factors and Perspectives by Transparency Market Research 4Health News:New Eco-Pro Premium Anti-fatigue Mats from Martinson-Nicholls Prevent Fatigue and Discomfort for Standing Workers 2Health News:REMIND-A-CAP™ , A New York City Based Company Invents Groundbreaking Prescription Cap to Curb Non-Adherence 2Health News:‘Voices of Arthritis’ Launches Awareness Month 2Health News:‘Voices of Arthritis’ Launches Awareness Month 3Health News:Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis 2Health News:Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis 3Health News:Drug that improves blood flow may help find cause of exercise intolerance in cystic fibrosis 4
... Opus Healthcare Solutions, Inc., a ... today that OpusMobility(R) runs on ... ) , (Logo: http://www.newscom.com/cgi-bin/prnh/20080325/LATU040LOGO ) Opus ... or Wi-Fi connections on all smart phone devices ...
... January 13, 2009 A benchmarking study ... evaluated contemporary hospital glycemic management in United ... are suboptimal and do not meet current American ... The retrospective cohort study was based upon a ...
... its annual Molecular Imaging Summit to introducing the new ... Hilton Clearwater Hotel, Clearwater, Fl. In part, the program ... Network, which was designed to facilitate cost-effective drug development ... 2, 3 and 4 therapeutics clinical trials. In addition, ...
... health care policyWASHINGTON, Jan. 13 The RAND ... policymakers and interested parties with a unique way ... consequences of health care reform proposals certain to ... beyond. COMPARE (Comprehensive Assessment of Reform Efforts) is ...
... ATLANTA, Jan. 13 Vendormate nearly tripled its customer,base ... in 42 states across the,U.S. in part because of ... help mitigate the risk of supply chain,interruptions. , ... and financial service,providers in particular are anxious about their ...
... Family,Services, Inc. No. 2851 on its annual ranking of ... marks the second consecutive year that,Access Family Services has ... the most,comprehensive look at the most important segment of ... whole, these companies represent,the backbone of the U.S. economy. ...
Cached Medicine News:Health News:OpusMobility(R) Clinical Information System Runs on Google G1 Smart Phone 2Health News:OpusMobility(R) Clinical Information System Runs on Google G1 Smart Phone 3Health News:Annual SNM MI summit introduces the clinical trials network 2Health News:RAND Launches Unique Tool to Evaluate Health Care Proposals 2Health News:RAND Launches Unique Tool to Evaluate Health Care Proposals 3Health News:RAND Launches Unique Tool to Evaluate Health Care Proposals 4Health News:Economic Uncertainty Fuels Vendormate Growth in 2008 2Health News:Access Family Services, Inc. Makes the List for the Second Year in a Row! Access Family Services 2008 Ranks No. 2851 on the Inc. 5000 With Three-Year Sales Growth of 128% 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: